Skip to content

Adynxx, Inc.

Delisted

CIK 1054274fmd_1BZXR8AE1QG55BRT764Z75WDH1Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2019, 38 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018
Total revenues12125121622
Cost of revenue222235622
Net interest income–––––––(1)(1)
Gross profit(1)(0)(1)(0)271000
Provision for credit losses–––––01(1)0
Research and development010001192
Net interest income after provision–––––––0(1)
Selling, general and administrative2441226343555
Total operating expenses214420273642115
Operating income(3)(14)(5)(20)(25)(30)(32)(11)(5)
Interest expense0(0)0002311
Interest and investment income0(0)0000000
Other non-operating income (expense)(0)00(2)(0)1(2)00
Income before taxes–––(22)(25)(29)(34)(4)(7)
Income tax expense–0000(2)(1)00
Net income from continuing operations–––(22)(25)(27)(33)(4)(7)
Net income(3)(14)(5)(22)(25)(26)(28)(12)(6)
Net income to common shareholders––(5)(22)(25)––––
Adynxx, Inc. financial statements · FinancialMD